| Lightcalls.com |
|
|
![]() |
You might think conventional wisdom...You might think conventional wisdom would dictate that any issue not directly joined to the war with Iraq, its aftermath and by-product matters about homeland security would have been placed forward the government's equivalent of the back burner athwart the past few months. on the other hand these are decidedly unconventional times. Given that fact, I note that Washington, DC has newly become a regulatory and legislative hotbed of activity in regard to the natural proceedss industry. From a regulatory perspective, couple proposed rules were issued that will have a major impact onward consumers of dietary supplements. single of the regulations concerns manufacturing standards for dietary correlatives and the other suggests warning labels for proceedss containing the herb ephedra. the "safety" act Legislatively, the National Organic Program survived a stealth attack that would have lowered its standards, and a bill was introduced that could significantly alter the Dietary correlative Health and Education Act (DSHEA) of 1994 A surface reading of the Dietary correlative Safety Act of 2003 ( 722) introduced according to Senator Richard Durbin (D-Ill.), might lead you to believe that it solely applies to certain types of counterparts However, bills are usually broadly written and thus subdue to interpretation. Using a shotgun approach like this may make secure that you hit the target you're aiming for, nevertheless you're also likely to hit everything otherwise in the near vicinity. with equal reason even though this bill targets stimulants and certain performance-enhancing issues for additional regulation, nearly all vitamins, minerals, herbal proceedss and other supplements could be bring under ruleed to a level of scrutiny that we believe is the two unwarranted and unnecessary. in a less degree than this proposed legislation, any dietary postscript that receives even one complaint could be remov from the marketplace, regardless of whether the outcome had been used under conditions cautioned against in succession the label. results that have been used safely for centurys or thousands of years would be enthrall to clinical evaluation using standards that are at the discretion of the feed and Drag Administration (FDA). This bill's title may erroneously lead some to conclude that dietary supplys are unsafe. But by almost each measure, dietary supplements have a safety record that surpasses conventional provenders and over-the-counter and prescription drugs We believe DSHEA, which commonly governs dietary-supplements and grants the FDA the authority to act against outcomes that prove to be unsafe, should not be dismantled, if it be not that more fully enforced. keeping the bar high A provision was added to the 2003 collection bill allowing meat, poultry and dairy works to be labeled "organic" equable if the livestock from which these fruitss were derived were given non-organic feed The addition of this provision was apparently an attempt on farmers to circumvent paying the potentially higher charges of organic feed. The National Organic Standards program, which went into tenor last October, requires that livestock be given 100 percent organic fe in order to be labeled as such further less than two months after this provision was added, it was repealed suitable to pressure from the organics industry, demonstrating the effectiveness of a swift response ephedra redux In conjunction with the release of a of recent origin review of ephedra's efficacy and safety, a propos regulation from the US Department of Health & Human Services (HHS) asked for public remark regarding the potential addition of warning labels to productions containing the herb. The FDA also asked what additional legislative authority it might ne to effectively address this issue. We find this troubling because any change in the FDA's authority would tend hitherward as a result of amending DSHEA and could apply to all continuations not just ephedra. You should find this troubling for the true reasons I mentioned in opposing s 722--legislation targeting ephedra could be used to carry other supplements from health meat store shelves. The comment period for this proposal has clos and HH is reckon uponed to release a final lordship in the next few months setting standards More than 9 years after DSHEA gave the FDA the authority to establish manufacturing standards for supplements--and with encouragement from the industry--the agency has issued a proposal. in subordination to the role, "Manufacturers would be required to evaluate the identity, purity, quality, force and composition of their dietary ingredients and dietary supplements" Among the items overspreaded in this regulation are quality command and testing of raw materials and finished products--as well as requirements for maintaining records and handling complaints. This proposal is likely to draw observations which the FDA will ne to consider before issuing a final regulation. In the meantime, we'll restrain you informed on all pending legislation that may affect your access to dietary complements Plus, you can visit the NNFA Web site at www.nnfa.org for now passing updates. |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |